Accreditation

Upon completion of these educational activities, participants will be able to:

  1. Discuss the key updates from the 2017 GOLD Guidelines and their application to the diagnosis and management of COPD.
  2. Select appropriate therapies based on the new 2017 GOLD Guidelines for management of COPD.
  3. Review effective communication strategies to improve engagement and self-management for patients with COPD.
  4. Recognize the role of exacerbations in the management of COPD.

Module 1: Initial Assessment and Management of Stable COPD

CME Credit: .50

In this module, Dr. Serban, discussed the initial assessment and management of stable patients with COPD, as well as the importance of return demonstration for patients who use inhaler devices.

Module 2:  Learning to Assess and Manage Patients with Frequent COPD Exacerbations: Changing the Future by Planning Today

CME Credit: .50

In this module, Dr Finigan, outlined the goals and treatment options for those patients experiencing frequent COPD exacerbations.

Module 3: COPD Roundtable

CME Credit: 1.0

In this module, expert faculty participate in a roundtable discussion about the newly updated GOLD Guidelines, as well as asking you, the viewer, questions related to the management of COPD.

Target Audience

Primary Care Physicians and Community Pulmonologists, Nurse Practitioners, Physician Assistants, and nurses who are involved in the management of COPD.

Accreditation Statement

National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

National Jewish Health designates these courses with the following credit totals.

  • Module 1:  .5 AMA PRA Category 1 Credits
  • Module 2:  .5 AMA PRA Category 1 Credits
  • Module 3:  1.0 AMA PRA Category 1 Credits

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Program Support

This activity is supported by independent educational grants from AstraZeneca Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals, and Sunovion Pharmaceuticals.

Requirements for Successful Completion

In order to receive credit, participants must complete the pre-test, view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test with a passing score of ≥ 75%, and evaluation form.

Faculty & Disclosure Information

In accordance with ACCME requirements, National Jewish Health has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.

Steven Lommatzsch, MD (Program Chairman)

Assistant Professor
Division of Pulmonary, Critical Care and Sleep Medicine
Department of Medicine
National Jewish Health, Denver, CO

Dr. Lommatzsch declares that he is an advisory board member for AstraZeneca, an investigator for Corbus and a speaker for Catamount Education.

Anthony Gerber, MD, PhD

Anthony Gerber, MD, PhD
Associate Professor
Division of Pulmonary, Critical Care and Sleep Medicine
Department of Medicine
Department of Biomedical Research
National Jewish Health, Denver, CO

Dr. Gerber declares that he is a consultant for Revon Systems.

Amen Sergew, MD

Assistant Professor
Department of Medicine
Division of Pulmonary, Critical Care and Sleep Medicine
Section of Critical Care Medicine
National Jewish Health, Denver, CO

Dr. Sergew has no financial interests/relationships or affiliations in relation to this activity.

James Finigan, MD

Director, The Respiratory Centers of Excellence
Medical Director, Lung Cancer Screening Program
Associate Professor
Division of Pulmonary, Critical Care & Sleep Medicine
Division of Oncology, Cancer Center
Department of Medicine
National Jewish Health – Denver, CO

Dr. Finigan has no financial interests/relationships or affiliations in relation to this activity.

Ed Farrell, MD

Medical Director, Clinica Family Health Services
Associate Clinical Professor
Department of Family Medicine
University of Colorado Health Sciences Center, School of Medicine

Dr. Farrell has no financial interests/relationships or affiliations in relation to this activity.

Karina Serban, MD

Assistant Professor
Department of Medicine
Division of Pulmonary, Critical Care and Sleep Medicine
National Jewish Health, Denver, CO

Dr. Serban has no financial interests/relationships or affiliations in relation to this activity.

Faculty Reviewers

Dr. Harold Nelson
Professor of Medicine
National Jewish Health, Denver, CO
Dr. Nelson declares that he is a Consultant for Merck and an Investigator for Circassia.

Dr. Ronina Covar
Associate Professor of Medicine
National Jewish Health, Denver, CO
Dr. Covar declares that she is an Advisory Board Member for Novartis/Genentech, a Consultant for GlaxoSmithKline and Novartis Genentech and an Investigator for AstraZeneca and Roche.

Planners

Andrea Harshman, MHA, CHCP, CMP-HC
Director
Office of Professional Education
National Jewish Health, Denver, CO
Ms. Harshman has no financial interests/relationships or affiliations in relation to this activity.

Matthew Stern
Medical Education Project Specialist
Office of Professional Education
National Jewish Health, Denver, CO
Mr. Stern has no financial interests/relationships or affiliations in relation to this activity.

CME Disclaimer

 

National Jewish Health (”NJH”) and its officers, Board of Directors, faculty, employees, representatives, and other agents (collectively, “NJH Parties”) shall not be responsible in any capacity for, and do not warrant any content whatsoever, in any NJH publication or other product (in any medium), or the use or reliance on any such content, and expressly disclaim any and all liability for such content. All such responsibility for content and use of product solely rests with the authors or the advertisers, as the case may be.

By way of example, without limiting the foregoing, this disclaimer of liability applies to the accuracy, completeness, effectiveness, quality, appearance, ideas, or products, as the case may be, of or resulting from, any statements, references, articles, positions, claimed diagnosis, claimed possible treatments, services, or advertising, express or implied, contained in any NJH live meeting, publication, online course or other product.

Furthermore, the content should not be considered medical advice and is not intended to replace consultation with a qualified medical professional. Under no circumstances, including negligence, shall any of the NJH Parties be liable for any DIRECT, INDIRECT, INCIDENTAL, SPECIAL or CONSEQUENTIAL DAMAGES, or LOST PROFITS that result from any of the foregoing, regardless of legal theory and whether or not claimant was advised of the possibility of such damages.

 

Hardware/Software Requirements

To access these activities, users will need:

A computer with an Internet connection, Adobe Flash Player and/or an HTML5 capable browser for video playback

Internet Explorer 10+
Firefox 8+
Safari 6+
or any other W3C standards
compliant browser

Adobe Acrobat Reader

We recommend a device that has a display capability of 1024 x 768 or better
Mobile devices are okay for this activity but to get the best experience a tablet device or larger is recommended.

Contact Information

For questions regarding this activity, please contact the Office of Professional Education at National Jewish Health:
303.398.1000 or proed@njhealth.org.